the patent is titled "injectable ready-to-use solutions containing an antitumor anthracycline glycoside".
in identifying that substance, claim 1 refers to a "sterile, pyrogen-free, anthracycline glycoside solution".
this integer described a characteristic of the sterile, pyrogen-free anthracycline glycoside solution identified in claim 1.